202 related articles for article (PubMed ID: 30165205)
41. Comparison of Cobas® HPV and Anyplex™ II HPV28 assays for detecting and genotyping human papillomavirus.
Pasquier C; Sauné K; Raymond S; Boisneau J; Courtade M; Izopet J
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):25-27. PubMed ID: 28336133
[TBL] [Abstract][Full Text] [Related]
42. Comparing self- and provider-collected swabbing for HPV DNA testing in female-to-male transgender adult patients: a mixed-methods biobehavioral study protocol.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh T; Pardee DJ; McLean S; Marrow EJ; Mimiaga MJ; Panther L; Gelman M; Green J; Potter J
BMC Infect Dis; 2017 Jun; 17(1):444. PubMed ID: 28645254
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.
Zhang L; Dai Y; Chen J; Hong L; Liu Y; Ke Q; Chen Y; Cai C; Liu X; Chen Z
J Med Virol; 2018 Jan; 90(1):177-183. PubMed ID: 28851089
[TBL] [Abstract][Full Text] [Related]
44. Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay.
Catarino R; Vassilakos P; Bilancioni A; Bougel S; Boukrid M; Meyer-Hamme U; Petignat P
PLoS One; 2017; 12(7):e0181905. PubMed ID: 28750015
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of YD MolecuTech Real HPV Assay in Comparison with Roche Cobas HPV Assay and BD Onclarity HPV Assay for Detection of HPV Infection.
Park CH; Kim CW; Lee HW; Kwon MJ
Ann Clin Lab Sci; 2024 Mar; 54(2):239-245. PubMed ID: 38802145
[TBL] [Abstract][Full Text] [Related]
46. PCR-RFLP assay as an option for primary HPV test.
Golfetto L; Alves EV; Martins TR; Sincero TCM; Castro JBS; Dannebrock C; Oliveira JG; Levi JE; Onofre ASC; Bazzo ML
Braz J Med Biol Res; 2018 Mar; 51(5):e7098. PubMed ID: 29590262
[TBL] [Abstract][Full Text] [Related]
47. Human papillomavirus typing by single tube multiplex amplification in real time (SMART): the PapillomaFinder® SMART 20 assay.
Ossel J; Litjens RJ; Reijans M; Brink AA; Ummelen M; Ramaekers FC; Hopman AH; Simons G
J Clin Virol; 2014 Dec; 61(4):540-7. PubMed ID: 25453331
[TBL] [Abstract][Full Text] [Related]
48. An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium.
Dong L; Lin C; Li L; Wang M; Cui J; Feng R; Liu B; Wu Z; Lian J; Liao G; Chen W; Qiao Y
J Clin Virol; 2017 Sep; 94():67-71. PubMed ID: 28763729
[TBL] [Abstract][Full Text] [Related]
49. Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping.
Ge S; Gong B; Cai X; Yang X; Gan X; Tong X; Li H; Zhu M; Yang F; Zhou H; Hong G
Cancer Med; 2012 Aug; 1(1):59-67. PubMed ID: 23342254
[TBL] [Abstract][Full Text] [Related]
50. Self-collected and clinician-collected anal swabs show modest agreement for HPV genotyping.
Dube Mandishora RS; Rounge TB; Fitzpatrick M; Christiansen IK; Ambur OH; Lagström S; Stray-Pedersen B; Tommasino M; Palefsky J; Chirenje ZM
PLoS One; 2021; 16(4):e0250426. PubMed ID: 33901223
[TBL] [Abstract][Full Text] [Related]
51. Detection and genotyping of human papillomavirus in self-obtained cervicovaginal samples by using the FTA cartridge: new possibilities for cervical cancer screening.
Lenselink CH; de Bie RP; van Hamont D; Bakkers JM; Quint WG; Massuger LF; Bekkers RL; Melchers WJ
J Clin Microbiol; 2009 Aug; 47(8):2564-70. PubMed ID: 19553570
[TBL] [Abstract][Full Text] [Related]
52. Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
Lee H; Choi M; Jo M; Park EY; Hwang SH; Cho Y
Gynecol Oncol; 2020 Mar; 156(3):641-646. PubMed ID: 31926639
[TBL] [Abstract][Full Text] [Related]
53. Comparison of clinical performance of two high-throughput liquid bead microarray assays, GeneFinder and CareGENE, for cervical screening in the general population.
Moon JH; Jeong K; Kim K; Lee C; Jin MS; Ryu HS
Arch Virol; 2019 Nov; 164(11):2699-2706. PubMed ID: 31435867
[TBL] [Abstract][Full Text] [Related]
54. Prevalence of High-Risk Human Papillomavirus by RNA Assay in Home Self-Collected Samples Among Underscreened People in North Carolina.
Lee F; Bukowski A; Spees LP; Wheeler SB; Brewer NT; Sanusi B; Hudgens MG; Jackson S; Barclay L; Carter A; Tang JH; Smith JS
Sex Transm Dis; 2022 Mar; 49(3):244-249. PubMed ID: 34535615
[TBL] [Abstract][Full Text] [Related]
55. Comparison of the performance of carcinogenic HPV typing of the Roche Linear Array and Qiagen LiquiChip® HPV assays.
Halfon P; Sandri MT; Raimondo A; Ravet S; Khiri H; Sideri M; Penaranda G; Camus C; Mateos Lindemann ML
BMC Infect Dis; 2013 Oct; 13():499. PubMed ID: 24156822
[TBL] [Abstract][Full Text] [Related]
56. Evaluating the PGMY-centre hospitalier universitaire vaudois assay as a cost-effective tool for human papillomavirus genotyping in HIV-infected women.
Baliga PR; Anantharam R; Thomas V; Rupali P; Chopra M; Pulimood S; Lionel J; Peedicayil A; Kannangai R; Gnanamony M; Abraham P
Indian J Med Microbiol; 2019; 37(4):542-548. PubMed ID: 32436878
[TBL] [Abstract][Full Text] [Related]
57. Comparative evaluation of Anyplex II HPV28 and Allplex HPV28 molecular assays for human papillomavirus detection and genotyping in anogenital cancer screening.
Naegele K; Bubendorf L; Hirsch HH; Leuzinger K
J Med Virol; 2024 Jun; 96(6):e29649. PubMed ID: 38812416
[TBL] [Abstract][Full Text] [Related]
58. An economical Nanopore sequencing assay for human papillomavirus (HPV) genotyping.
Chan WS; Chan TL; Au CH; Leung CP; To MY; Ng MK; Leung SM; Chan MKM; Ma ESK; Tang BSF
Diagn Pathol; 2020 May; 15(1):45. PubMed ID: 32375813
[TBL] [Abstract][Full Text] [Related]
59. Performance and pre-analytical stability of self-collected samples versus clinician cervical samples for the detection of HPV16, HPV18 and a pool of 12 other HPV types on the Roche Cobas 8800 System.
Ilardo C; Marguerettaz M; Breton A; Azzoug T; Schmitt N; Fournier R; Bayette J; Teissier G; Lelarge C; Ponseille B
New Microbiol; 2022 Apr; 45(2):111-114. PubMed ID: 35699559
[TBL] [Abstract][Full Text] [Related]
60. Development of high-throughput genotyping method of all 18 HR HPV based on the MALDI-TOF MS platform and compared with the Roche Cobas 4800 HPV assay using clinical specimens.
Cai X; Guan Q; Huan Y; Liu Z; Qi J; Ge S
BMC Cancer; 2019 Aug; 19(1):825. PubMed ID: 31438998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
